Table 2: T2DM GWA results showing SNPs that reached genome-wide significance (<5 × 10−8) in the initial testing phase or after conditioning for sex, age, and BMI

From: T2DM GWAS in the Lebanese population confirms the role of TCF7L2 and CDKAL1 in disease susceptibility

     Additive modelAdjusted for sexAdjusted for ageAdjusted for BMIAdjusted for sex, age, and BMI
SNPImputationChrgeneMAFOR95%CIp-valueOR95%CIp-valueOR95%CIp-valueOR95%CIp-valueOR95%CIp-value
rs7766070imputed6CDKAL10.291.381.24-1.549.37E-091.381.24-1.541.71E-081.381.24-1.544.64E-091.391.24-1.556.83E-091.391.25-1.554.77E-09
rs9348441imputed6CDKAL10.291.381.24-1.531.38E-081.381.24-1.532.33E-081.381.24-1.537.16E-091.381.24-1.549.26E-091.391.24-1.556.38E-09
rs35261542imputed6CDKAL10.291.381.23-1.532.75E-081.381.23-1.534.58E-081.381.23-1.541.56E-081.391.24-1.551.93E-081.391.24-1.551.45E-08
rs7451008imputed6CDKAL10.291.371.23-1.533.18E-081.371.23-1.535.16E-081.371.23-1.531.91E-081.391.24-1.551.63E-081.391.24-1.551.31E-08
rs1569699genotyped6CDKAL10.381.331.21-1.483.51E-081.331.21-1.487.11E-081.341.21-1.481.74E-081.351.22-1.491.85E-081.351.22-1.491.49E-08
rs9368222imputed6CDKAL10.291.361.22-1.524.02E-081.361.22-1.526.46E-081.371.23-1.522.18E-081.371.23-1.532.49E-081.381.23-1.531.65E-08
rs9350271imputed6CDKAL10.371.331.2-1.474.64E-081.331.2-1.479.50E-081.331.21-1.482.18E-081.341.21-1.493.40E-081.341.21-1.492.59E-08
rs10946396imputed6CDKAL10.381.331.2-1.475.56E-081.331.2-1.471.04E-071.331.2-1.472.49E-081.341.21-1.485.23E-081.341.21-1.484.08E-08
rs6456369imputed6CDKAL10.381.331.2-1.477.72E-081.331.2-1.471.36E-071.331.2-1.473.38E-081.331.2-1.487.33E-081.331.2-1.485.20E-08
rs6456368imputed6CDKAL10.311.351.21-1.58.23E-081.351.21-1.51.32E-071.351.21-1.53.88E-081.351.21-1.59.80E-081.351.21-1.56.91E-08
rs7754840imputed6CDKAL10.311.341.21-1.499.67E-081.341.21-1.491.48E-071.341.21-1.494.45E-081.351.21-1.51.02E-071.351.21-1.56.71E-08
rs4710940imputed6CDKAL10.381.321.2-1.469.77E-081.321.2-1.461.83E-071.331.2-1.474.35E-081.331.2-1.478.27E-081.331.2-1.486.28E-08
rs35456723imputed6CDKAL10.31.351.21-1.51.02E-071.351.21-1.51.66E-071.351.21-1.54.86E-081.351.21-1.51.03E-071.351.21-1.57.44E-08
rs9295474imputed6CDKAL10.311.351.21-1.51.07E-071.351.21-1.51.69E-071.351.21-1.55.19E-081.361.22-1.516.71E-081.361.22-1.514.51E-08
rs7756992genotyped6CDKAL10.31.341.21-1.491.08E-071.341.21-1.491.78E-071.341.21-1.55.14E-081.351.21-1.516.63E-081.351.22-1.514.33E-08
rs6456367imputed6CDKAL10.311.341.21-1.491.10E-071.341.21-1.491.71E-071.341.21-1.494.94E-081.351.21-1.51.09E-071.351.21-1.57.07E-08
chr6:20660689:Dimputed6CDKAL10.371.331.2-1.471.11E-071.331.2-1.471.96E-071.331.2-1.474.96E-081.331.2-1.481.03E-071.331.2-1.487.54E-08
rs7752780imputed6CDKAL10.311.341.21-1.491.11E-071.341.21-1.491.71E-071.341.21-1.494.93E-081.341.21-1.51.15E-071.351.21-1.57.31E-08
rs34872471imputed10TCF7L20.41.321.19-1.468.30E-081.321.19-1.461.51E-071.321.2-1.464.80E-081.351.22-1.499.91E-091.351.22-1.51.01E-08
rs35198068imputed10TCF7L20.41.311.19-1.451.12E-071.311.19-1.452.03E-071.321.19-1.466.61E-081.341.21-1.491.38E-081.351.22-1.491.42E-08
rs7903146genotyped10TCF7L20.41.311.19-1.451.39E-071.311.19-1.452.44E-071.311.19-1.458.38E-081.341.21-1.481.74E-081.341.21-1.491.79E-08
rs4506565imputed10TCF7L20.411.311.18-1.441.60E-071.311.18-1.442.70E-071.311.19-1.459.64E-081.341.21-1.482.00E-081.341.21-1.481.96E-08
rs7901695genotyped10TCF7L20.411.31.18-1.433.23E-071.31.18-1.435.53E-071.31.18-1.442.03E-071.331.2-1.474.35E-081.331.2-1.474.50E-08